Statins and Non-Alcoholic Fatty Liver Disease Progression: Further Comments

被引：0
|
作者：
Athyros, Vasilios G. [1 ]
Koumaras, Charalambos [2 ]
Sfikas, George [2 ]
机构：
[1] Aristotle Univ Thessaloniki, Sch Med, Hippocrat Hosp, Propedeut Dept Internal Med 2, Marmara 15, Thessaloniki 55132, Greece
[2] 424 Mil Gen Training Hosp, 1st Internal Med Clin, Thessaloniki, Greece
来源：
CURRENT VASCULAR PHARMACOLOGY | 2021年 / 19卷 / 06期
关键词：
CORONARY-HEART-DISEASE; STEATOHEPATITIS; ATORVASTATIN; RISK;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：673 / 674
页数：2
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [42] An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease
    Lee, Eunyoung
    Korf, Hannelie
    Vidal-Puig, Antonio
    JOURNAL OF HEPATOLOGY, 2023, 78 (05) : 1048 - 1062
  • [43] Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
    Zhou, Jin
    Tripathi, Madhulika
    Sinha, Rohit A.
    Singh, Brijesh Kumar
    Yen, Paul M.
    HEPATOMA RESEARCH, 2021, 7
  • [44] Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease
    Nakahara, Takashi
    Hyogo, Hideyuki
    Ono, Atsushi
    Nagaoki, Yuko
    Kawaoka, Tomokazu
    Miki, Daiki
    Tsuge, Masataka
    Hiraga, Nobuhiko
    Hayes, Clair Nelson
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Ochi, Hidenori
    Abe-Chayama, Hiromi
    Furusho, Hisako
    Shintani, Tomoaki
    Kurihara, Hidemi
    Miyauchi, Mutsumi
    Takata, Takashi
    Arihiro, Koji
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (02) : 269 - 280
  • [45] Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
    Parameswaran, Madhangi
    Hasan, Hamzah A.
    Sadeque, Jafor
    Jhaveri, Sharan
    Avanthika, Chaithanya
    Arisoyin, Abimbola E.
    Dhanani, Maulik B.
    Rath, Swaroopa M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [46] The presence of interferon affects the progression of non-alcoholic fatty liver disease
    Michelle Møhlenberg
    Peter Lykke Eriksen
    Tea Lund Laursen
    Mette Bak Nielsen
    Stephen Jacques Hamilton Dutoit
    Henning Grønbæk
    Rune Hartmann
    Karen Louise Thomsen
    Genes & Immunity, 2022, 23 : 157 - 165
  • [47] The presence of interferon affects the progression of non-alcoholic fatty liver disease
    Mohlenberg, Michelle
    Eriksen, Peter Lykke
    Laursen, Tea Lund
    Nielsen, Mette Bak
    Dutoit, Stephen Jacques Hamilton
    Gronbaek, Henning
    Hartmann, Rune
    Thomsen, Karen Louise
    GENES AND IMMUNITY, 2022, 23 (05) : 157 - 165
  • [48] Ductular reaction predicts the progression of non-alcoholic fatty liver disease
    Younes, Ramy
    McPherson, Stuart
    Bugianesi, Elisabetta
    Anstee, Quentin
    Tiniakos, Dina
    Govaere, Olivier
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E552 - E553
  • [49] Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease
    Takashi Nakahara
    Hideyuki Hyogo
    Atsushi Ono
    Yuko Nagaoki
    Tomokazu Kawaoka
    Daiki Miki
    Masataka Tsuge
    Nobuhiko Hiraga
    Clair Nelson Hayes
    Akira Hiramatsu
    Michio Imamura
    Yoshiiku Kawakami
    Hiroshi Aikata
    Hidenori Ochi
    Hiromi Abe-Chayama
    Hisako Furusho
    Tomoaki Shintani
    Hidemi Kurihara
    Mutsumi Miyauchi
    Takashi Takata
    Koji Arihiro
    Kazuaki Chayama
    Journal of Gastroenterology, 2018, 53 : 269 - 280
  • [50] The Lipidomic Signature Of Disease Progression In Non-alcoholic Fatty Liver Disease (NAFLD)
    Alonso, Cristina
    Asgharpour, Amon
    Martinez-Arranz, Ibon
    Puri, Puneet
    Siddiqui, Mohammad S.
    Ortiz, Pablo
    Mato, Jose M.
    Sanyal, Arun J.
    HEPATOLOGY, 2015, 62 : 1262A - 1262A
12345